TokenPost·

NervGen Pharma’s Net Loss Rises 36% to C$6.4 Million

Your call?
C$6.4M
quarterly net loss

Research and development expenses rose 84% to C$7.9 million, while general and administrative expenses increased 154% to C$3.3 million.

Share

More news